Pierre Ruffiè - Concepedia

Author

Pierre Ruffiè

Institut Gustave Roussy

Also Known As

P RUFFIE, P Ruffie, P Ruffié, P. Ruffie, P. Ruffié, Pierre A. Ruffie, Pierre Ruffie, Pierre Ruffiè, Pierre Ruffié

127

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Institut Gustave Roussy Hôpital Intercommunal de Créteil Institut Bergonié Institute Mutualiste Montsouris Pierre Fabre (France)

About

Pierre Ruffiè is an author at Institut Gustave Roussy specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	2K
2	Health Sciences	7	7	617
3	Public Health	1	1	11
4	Clinical Nutrition	1	1	11
5	Endocrinology	1	1	250

Pierre Ruffiè

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Journal of Clinical Oncology	2003	3K
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Pierre Ruffiè, R. Feld, Salomon Minkin, Journal of Clinical Oncology Retrospective StudyAppropriate Stratification VariablesTumoral PathologyWeight LossMedicine	1989	371
Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients R. Arriagada, Thierry Le Chevalier, Elizabeth Quoix, International Journal of Radiation OncologyBiologyPhysics Randomized StudyMedicineBronchial NeoplasmCancer TreatmentAstro Plenary	1991	267
Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer R. Arriagada, Thierry Le Chevalier, Jean‐Pierre Pignon, New England Journal of Medicine	1993	252
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Journal of Clinical Oncology	2023	251
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours Éric Baudin, Agostino Gigliotti, Michel Ducreux, British Journal of Cancer Neuron-specific EnolaseNeuro-oncologyRadiation OncologyTumor InnervationNeuroendocrine Disorder	1998	250
Pleural effusion: laboratory tests in 300 cases. A Hirsch, Pierre Ruffiè, M Nebut, Thorax Open Pleural BiopsyPulmonary TuberculosisPulmonary PathologyPneumothoraxTuberculosis Prevention	1979	206
Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. P Girard, Michel Ducreux, P Baldeyrou, Journal of Clinical Oncology	1996	189
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma Thierry Le Chevalier, R. Arriagada, Elizabeth Quoix, Lung Cancer Adaptive RadiotherapyRadiation TherapyMedicineBronchial NeoplasmOncology	1994	147
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma T. Delaunoit, Michel Ducreux, Valérie Boige, European Journal of Cancer Surgical OncologyPancreatic CancerMedicinePharmacologyDoxorubicin-streptozotocin Combination	2003	138

Page 1